Skip to main content
NIH funding notice PAR-21-312

Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)

Closed on January 25, 2024.

Posted
October 5, 2021
Close date
January 25, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $971,847 in first-year total cost, median $485,924.

Most frequent study sections

  1. Special Emphasis Panel[ZHG1 HGR-W (O1)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
Competing awards under PAR-21-312 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Genomic Medicine Master of Science (M.S.) Degree Program1R25HG012726-01A1SOBREIRA, NARAJOHNS HOPKINS UNIVERSITY, MD$486,000ZHG1
2024Genomic Medicine Master's Degree Program for Medical Students1R25HG012725-01A1HYLAND, KATHERINERISCH, NEIL J.UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$485,847ZHG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-21-312: Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed) | ScienceDex | ConductScience